Evelo Biosciences is a clinical-stage biotechnology company focused on developing orally delivered product candidates that act on cells in the small intestine. Their goal is to harness SINTAX to modulate the body's immune system and improve healthcare.

Non-Executive Director Evelo Biosciences, profile picture · Non-Executive Director Evelo Biosciences. Non-executive Director. July 7, 2022 to present.

Evelo Biosciences. @EveloBio. Clinical stage biotech company developing a new modality of oral biologics that act on cells in the small intestine with ...

Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal ...

Evelo Biosciences

Find contacts at this company